title: [Use of recombinant factor VIIa to reduce transfusional load in hemorrhaging patients after surgery for malignant tumors].
abstract: Often expanded surgical interventions in patients with malignant tumors are accompanied by huge bleeding and require transfusion of big mass of medications prepared from donor blood that may develop different complications. It is showed that with the aim of treatment of hemorrhagic complications the use of recombination factor VIIa allows reducing the surgical blood loss, as well as diminishing hemotransfusional load after surgery especially in patients with malignancies of urogenital system and malignant tumors of the colon and lung.
authors.forename: A F
authors.initials: AF
authors.lastname: Lazarev
authors.forename: A V
authors.initials: AV
authors.lastname: Rossokha
authors.forename: A N
authors.initials: AN
authors.lastname: Mamaev
authors.forename: S A
authors.initials: SA
authors.lastname: Khodorenko
authors.forename: I V
authors.initials: IV
authors.lastname: Mamaeva
authors.forename: A V
authors.initials: AV
authors.lastname: Nazarov
authors.forename: L P
authors.initials: LP
authors.lastname: Tsyvkina
mesh_terms: D000328:Adult; D000368:Aged; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001803:Blood Transfusion / Q000706:statistics & numerical data*; D004906:Erythrocyte Count; D015942:Factor VIIa / Q000627:therapeutic use*; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000601:surgery*; D010949:Plasma; D011994:Recombinant Proteins / Q000627:therapeutic use; D013514:Surgical Procedures, Operative / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa